This is the first study to demonstrate that the small molecules CD, AD, TQ, and TQFL12 inhibit TMPRSS2 expression, which may have therapeutic roles via targeting TMPRSS2 to prevent SARS-CoV-2 invasion in cancer patients during the COVID-19 pandemic. Here, TMPRSS2 is linked to cancer.